477 related articles for article (PubMed ID: 8937280)
21. Clinical follow-up of responses to treatment with benznidazol in Amazon: a cohort study of acute Chagas disease.
Pinto AY; Valente Vda C; Coura JR; Valente SA; Junqueira AC; Santos LC; Ferreira AG; de Macedo RC
PLoS One; 2013; 8(5):e64450. PubMed ID: 23724050
[TBL] [Abstract][Full Text] [Related]
22. [Comparative controlled study on the use of benznidazole, nifurtimox and placebo, in the chronic form of Chagas' disease, in a field area with interrupted transmission. I. Preliminary evaluation].
Coura JR; de Abreu LL; Willcox HP; Petana W
Rev Soc Bras Med Trop; 1997; 30(2):139-44. PubMed ID: 9148337
[TBL] [Abstract][Full Text] [Related]
23. High seroconversion rates in Trypanosoma cruzi chronic infection treated with benznidazole in people under 16 years in Guatemala.
Brum-Soares L; Cubides JC; Burgos I; Monroy C; Castillo L; González S; Viñas PA; Urrutia PP
Rev Soc Bras Med Trop; 2016; 49(6):721-727. PubMed ID: 28001219
[TBL] [Abstract][Full Text] [Related]
24. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial.
Viotti R; Vigliano C; Lococo B; Bertocchi G; Petti M; Alvarez MG; Postan M; Armenti A
Ann Intern Med; 2006 May; 144(10):724-34. PubMed ID: 16702588
[TBL] [Abstract][Full Text] [Related]
25. Etiological treatment of young women infected with Trypanosoma cruzi, and prevention of congenital transmission.
Sosa-Estani S; Cura E; Velazquez E; Yampotis C; Segura EL
Rev Soc Bras Med Trop; 2009; 42(5):484-7. PubMed ID: 19967227
[TBL] [Abstract][Full Text] [Related]
26. Seronegative conversion after incomplete benznidazole treatment in chronic Chagas disease.
Alvarez MG; Vigliano C; Lococo B; Petti M; Bertocchi G; Viotti R
Trans R Soc Trop Med Hyg; 2012 Oct; 106(10):636-8. PubMed ID: 22898619
[TBL] [Abstract][Full Text] [Related]
27. [Chronic Chagas' disease: effects of treatment nn the levels of antibodies to crude and partially purified Trypanosoma cruzi antigens].
Moretti E; Cervetta L; Basso B; Castro I; Santamarina N
Bol Chil Parasitol; 1998; 53(1-2):3-9. PubMed ID: 9830716
[TBL] [Abstract][Full Text] [Related]
28. Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities.
Viotti R; Vigliano C; Lococo B; Alvarez MG; Petti M; Bertocchi G; Armenti A
Expert Rev Anti Infect Ther; 2009 Mar; 7(2):157-63. PubMed ID: 19254164
[TBL] [Abstract][Full Text] [Related]
29. Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy.
Morillo CA; Marin-Neto JA; Avezum A; Sosa-Estani S; Rassi A; Rosas F; Villena E; Quiroz R; Bonilla R; Britto C; Guhl F; Velazquez E; Bonilla L; Meeks B; Rao-Melacini P; Pogue J; Mattos A; Lazdins J; Rassi A; Connolly SJ; Yusuf S;
N Engl J Med; 2015 Oct; 373(14):1295-306. PubMed ID: 26323937
[TBL] [Abstract][Full Text] [Related]
30. The role of benznidazole with cyanocobalamin and ascorbic acid in treating the chronic phase of Chagas disease.
Ghobadifar MA; Kalani N; Gitiforouz M; Mosallanejad Z
Rev Soc Bras Med Trop; 2014; 47(5):669. PubMed ID: 25467275
[No Abstract] [Full Text] [Related]
31. Changes in the immune response after treatment with benznidazole versus no treatment in patients with chronic indeterminate Chagas disease.
Vallejo A; Monge-Maillo B; Gutiérrez C; Norman FF; López-Vélez R; Pérez-Molina JA
Acta Trop; 2016 Dec; 164():117-124. PubMed ID: 27619190
[TBL] [Abstract][Full Text] [Related]
32. Tolerance of benznidazole in treatment of Chagas' disease in adults.
Pinazo MJ; Muñoz J; Posada E; López-Chejade P; Gállego M; Ayala E; del Cacho E; Soy D; Gascon J
Antimicrob Agents Chemother; 2010 Nov; 54(11):4896-9. PubMed ID: 20823286
[TBL] [Abstract][Full Text] [Related]
33. New Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: a Pilot Short-Term Follow-Up Study with Adult Patients.
Álvarez MG; Hernández Y; Bertocchi G; Fernández M; Lococo B; Ramírez JC; Cura C; Albizu CL; Schijman A; Abril M; Sosa-Estani S; Viotti R
Antimicrob Agents Chemother; 2016 Feb; 60(2):833-7. PubMed ID: 26596935
[TBL] [Abstract][Full Text] [Related]
34. New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial.
Torrico F; Gascón J; Barreira F; Blum B; Almeida IC; Alonso-Vega C; Barboza T; Bilbe G; Correia E; Garcia W; Ortiz L; Parrado R; Ramirez JC; Ribeiro I; Strub-Wourgaft N; Vaillant M; Sosa-Estani S;
Lancet Infect Dis; 2021 Aug; 21(8):1129-1140. PubMed ID: 33836161
[TBL] [Abstract][Full Text] [Related]
35. Electrocardiographic Abnormalities and Treatment with Benznidazole among Children with Chronic Infection by Trypanosoma cruzi: A Retrospective Cohort Study.
Colantonio LD; Prado N; Segura EL; Sosa-Estani S
PLoS Negl Trop Dis; 2016 May; 10(5):e0004651. PubMed ID: 27158908
[TBL] [Abstract][Full Text] [Related]
36. Use of Trypanosoma cruzi purified glycoprotein (GP57/51) or trypomastigote-shed antigens to assess cure for human Chagas' disease.
Gazzinelli RT; Galvao LM; Krautz G; Lima PC; Cancado JR; Scharfstein J; Krettli AU
Am J Trop Med Hyg; 1993 Nov; 49(5):625-35. PubMed ID: 8250103
[TBL] [Abstract][Full Text] [Related]
37. Clinical and serological evolution in chronic Chagas disease patients in a 4-year pharmacotherapy follow-up: a preliminary study.
Andrade MC; Oliveira Mde F; Nagao-Dias AT; Coêlho IC; Cândido Dda S; Freitas EC; Coelho HL; Bezerra FS
Rev Soc Bras Med Trop; 2013; 46(6):776-8. PubMed ID: 24474023
[TBL] [Abstract][Full Text] [Related]
38. Technological innovation strategies for the specific treatment of Chagas disease based on Benznidazole.
Ferraz LRM; Alves AÉG; Nascimento DDSDS; Amariz IAE; Ferreira AS; Costa SPM; Rolim LA; Lima ÁAN; Rolim Neto PJ
Acta Trop; 2018 Sep; 185():127-132. PubMed ID: 29452113
[TBL] [Abstract][Full Text] [Related]
39. Treatment of congenital Chagas' disease diagnosed and followed up by the polymerase chain reaction.
Russomando G; de Tomassone MM; de Guillen I; Acosta N; Vera N; Almiron M; Candia N; Calcena MF; Figueredo A
Am J Trop Med Hyg; 1998 Sep; 59(3):487-91. PubMed ID: 9749649
[TBL] [Abstract][Full Text] [Related]
40. Variation in susceptibility to benznidazole in isolates derived from Trypanosoma cruzi parental strains.
Veloso VM; Carneiro CM; Toledo MJ; Lana M; Chiari E; Tafuri WL; Bahia MT
Mem Inst Oswaldo Cruz; 2001 Oct; 96(7):1005-11. PubMed ID: 11685270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
